Irinotecan/gemcitabine followed by twice-weekly gemcitabine/radiation in locally advanced pancreatic cancer.

Oncology (Williston Park, N.Y.)

Volumn 16, Issue 5 Suppl 5, 2002, Pages 25-28

  Blackstock, A William ^a   Melin, Susan A ^a   Butler, Jerome M ^a   Patton, Suzanne ^a   Pineau, Benjamin ^a   Albertson, David ^a   Howerton, Russell ^a   Levine, Edward ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; IRINOTECAN;

ADENOCARCINOMA; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DOSE RESPONSE; HUMAN; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; PANCREAS TUMOR; PATHOLOGY; PHASE 2 CLINICAL TRIAL;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEUTROPENIA; PANCREATIC NEOPLASMS;

EID: 0036559918     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)